$0.5800
0.001000.17%
At close: -
$0.5899
0.009901.71%
After Hours: Dec 27, 7:23 PM EDT
FibroGen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of FibroGen using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.17 | $-0.30 | 43.3 % |
Jun 2024 | 2024-08-06 | $-0.16 | $-0.26 | 38.5 % |
Mar 2024 | 2024-05-06 | $-0.33 | $-0.42 | 21.4 % |
Dec 2023 | 2024-02-26 | $-0.57 | $-0.42 | -35.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $46.33M | $34.76M | 33.3 % |
Jun 2024 | 2024-08-06 | $50.64M | $34.66M | 46.1 % |
Mar 2024 | 2024-05-06 | $55.90M | $36.67M | 52.4 % |
Dec 2023 | 2024-02-26 | $27.14M | $38.90M | -30.2 % |
FibroGen (FGEN) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.17, which beat the estimate of $-0.30.
The Actual Revenue was $46.3M, which beat the estimate of $34.8M.
Browse earnings estimates, EPS, and revenue on all stocks.